NDC 0245-0823 – Torpenz
Everolimus 5 mg/1 · Tablet · Oral
Product NDC0245-0823
Product details
- Brand name
- Torpenz
- Generic name
- Everolimus
- Labeler
- Upsher-Smith Laboratories, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA214182
- Marketed since
- October 1, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor; mTOR Inhibitor Immunosuppressant
Active ingredients
- Everolimus 5 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0245-0823-04 | 28 BLISTER PACK in 1 CARTON (0245-0823-04) / 1 TABLET in 1 BLISTER PACK (0245-0823-89) | Oct 21, 2025 |
| 0245-0823-30 | 30 TABLET in 1 BOTTLE (0245-0823-30) | Jun 24, 2024 |